Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhCC10 in premature neonates with respiratory distress syndrome
NCT01473264Phase 2Completed
- Sponsor
- Therabron Therapeutics
- Start
- Jan 2000
- Primary completion
- Jun 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of uteroglobin in respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), sponsored by Therabron Therapeutics. Started Jan 2000; status: completed.
02
Drugs
uteroglobin
03
Conditions
respiratory distress syndrome (RDS)bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT01473264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01473264.